Segelov, E., Wilson, K., Gebski, V., Waring, P. M., Tabernero, J., Wasan, H., … Shapiro, J. D. (2013). ICE CREAM: Irinotecan cetuximab evaluation and the cetuximab response evaluation among patients with G13D mutation. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 31). Chicago, IL: AMER SOC CLINICAL ONCOLOGY.

Segelov, Eva, Kate Wilson, Val Gebski, Paul Michael Waring, Josep Tabernero, Harpreet Wasan, Fortunato Ciardiello, et al. “ICE CREAM: Irinotecan cetuximab evaluation and the cetuximab response evaluation among patients with G13D mutation.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 31. AMER SOC CLINICAL ONCOLOGY, 2013.

Segelov E, Wilson K, Gebski V, Waring PM, Tabernero J, Wasan H, et al. ICE CREAM: Irinotecan cetuximab evaluation and the cetuximab response evaluation among patients with G13D mutation. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2013.

Segelov, Eva, et al. “ICE CREAM: Irinotecan cetuximab evaluation and the cetuximab response evaluation among patients with G13D mutation.” JOURNAL OF CLINICAL ONCOLOGY, vol. 31, no. 15, AMER SOC CLINICAL ONCOLOGY, 2013.

Segelov E, Wilson K, Gebski V, Waring PM, Tabernero J, Wasan H, Ciardiello F, Desai J, Underhill C, Karapetis CS, Khasraw M, Nott LA, Joubert WL, Pavlakis N, Van Hazel G, Chantrill LA, Price TJ, Jefford M, Haydon AM, Shapiro JD. ICE CREAM: Irinotecan cetuximab evaluation and the cetuximab response evaluation among patients with G13D mutation. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2013.